[{"address1": "9310 Athena Circle", "address2": "Suite 300", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "347-897-5988", "website": "https://turnstonebio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.", "fullTimeEmployees": 94, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sammy J. Farah M.B.A., Ph.D.", "age": 51, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 678512, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Venkat  Ramanan Ph.D.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 346132, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael F. Burgess M.D., MBChB, Ph.D.", "age": 59, "title": "Interim Chief Medical Officer & Executive Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 212690, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Saryah  Azmat", "age": 34, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": 479729, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vijay  Chiruvolu M.B.A., Ph.D.", "age": 61, "title": "Interim Chief Technology Officer", "yearBorn": 1962, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stewart  Abbot Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.16, "open": 3.08, "dayLow": 2.8801, "dayHigh": 3.405, "regularMarketPreviousClose": 3.16, "regularMarketOpen": 3.08, "regularMarketDayLow": 2.8801, "regularMarketDayHigh": 3.405, "forwardPE": -0.9198895, "volume": 212116, "regularMarketVolume": 212116, "averageVolume": 143561, "averageVolume10days": 149400, "averageDailyVolume10Day": 149400, "bid": 2.15, "ask": 3.9, "bidSize": 1800, "askSize": 800, "marketCap": 76900024, "fiftyTwoWeekLow": 1.625, "fiftyTwoWeekHigh": 13.2, "priceToSalesTrailing12Months": 2.584614, "fiftyDayAverage": 2.8274, "twoHundredDayAverage": 4.6340685, "currency": "USD", "enterpriseValue": -28526060, "profitMargins": -1.76174, "floatShares": 15225033, "sharesOutstanding": 23093100, "sharesShort": 392146, "sharesShortPriorMonth": 361772, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.017, "heldPercentInsiders": 0.06206, "heldPercentInstitutions": 0.67177004, "shortRatio": 2.52, "shortPercentOfFloat": 0.0242, "bookValue": 4.932, "priceToBook": 0.67518246, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -52475000, "trailingEps": -2.27, "forwardEps": -3.62, "enterpriseToRevenue": -0.959, "enterpriseToEbitda": 0.635, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TSBX", "underlyingSymbol": "TSBX", "shortName": "Turnstone Biologics Corp.", "longName": "Turnstone Biologics Corp.", "firstTradeDateEpochUtc": 1689946200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e04a4e6f-b2cf-301c-a72a-71f7773d1083", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.33, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.67, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 109105000, "totalCashPerShare": 4.725, "ebitda": -44953000, "totalDebt": 3679000, "quickRatio": 8.357, "currentRatio": 9.085, "totalRevenue": 29753000, "debtToEquity": 3.23, "revenuePerShare": 4.599, "operatingCashflow": -70156000, "grossMargins": -1.02427, "ebitdaMargins": -1.5108701, "operatingMargins": -1.6225901, "financialCurrency": "USD", "trailingPegRatio": null}]